Valiant Organics Q3 FY25 earnings call: Revenue & Margins
Q3 FY25 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹187Cr
- +32.6% YoY
- +16.9% QoQ
- Net profit
- ₹5Cr
- Turned profitable YoY
- Turned profitable QoQ
- Margin
- 8%
- +6.2 pp YoY
- +7.5 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q3 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q3-FY25 Consolidated Revenue from Operations: INR 1,869 Mn, up 32.2% YoY from INR 1,414 Mn (Page 12, 14). Q3-FY25 Consolidated Financials (Page 9 and 12): - EBITDA: INR 154 Mn, up from INR 38 Mn in Q3-FY24 (approx.
From Valiant Organics Ltd's Q3 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q3-FY25 Consolidated Revenue from Operations: INR 1,869 Mn, up 32.2% YoY from INR 1,414 Mn (Page 12, 14).
- Q3-FY25 Standalone Revenue from Operations: INR 1,869 Mn, up 32.2% YoY from INR 1,414 Mn (Page 14).
- Sales Volumes growth across key chemistries (Chlorination, Hydrogenation, Ammonolysis) shown with volumes increasing Q3-FY24 to Q3-FY25, e.g., Chlorination volumes rose from 366 MT to 879 MT (Page 11).
- 9M-FY25 Consolidated Revenue from Operations: INR 5,149 Mn, slight increase of 2.9% YoY from INR 5,004 Mn (Page 15).
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q3 FY25 results — key figures
| ₹ Cr | Q3 FY25 | Q3 FY24 | YoY | Q2 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue | 187 | 141 | +32.6% | 160 | +16.9% |
| Operating profit (EBITDA) | 15 | 3 | +400% | 1 | +1400% |
| Operating margin | 8% | 1.8% | +6.2 pp | 0.5% | +7.5 pp |
| Profit before tax | 6 | -10 | — | -14 | — |
| Net profit (PAT) | 5 | -8 | — | -12 | — |
| EPS (₹) | 1.98 | -2.86 | — | -4.63 | — |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Himadri Special (Q3 FY25)
1,131.81 Crs, up 7.53% YoY (from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Gujarat Alkalies (Q3 FY25)
3,702.77 Crores (up from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.
- Balaji Amines (Q3 FY25)
Q3FY25 consolidated revenue from operations was ₹321 crore, down 18% YoY from ₹392 crore in Q3FY24 (Page 7). Key concall takeaways from Balaji Amines Ltd's Q3…
- Vidhi Specialty (Q3 FY25)
Year-on-Year (Y-o-Y) Growth:** 56.5% increase . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY25 earnings call — and how it ranks…
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q3 FY25 results?
Q3-FY25 Consolidated Revenue from Operations: INR 1,869 Mn, up 32.2% YoY from INR 1,414 Mn (Page 12, 14). Q3-FY25 Consolidated Financials (Page 9 and 12): - EBITDA: INR 154 Mn, up from INR 38 Mn in Q3-FY24 (approx.
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
